π Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!
05.09.2025 12:00 β π 2 π 1 π¬ 0 π 0@ochoaallemantmd.bsky.social
GI Fellow #Penn Interested in preventing the development/progression of #SteatoticLiverDisease in high-risk patients Peruano
π Congratulations to Pedro Ochoa-Allemant of the University of Pennsylvania for receiving the 2025 #AASLDFoundation Anna S. Lok Advanced/Transplant #Hepatology Fellow Award!
05.09.2025 12:00 β π 2 π 1 π¬ 0 π 0New research out in @jamainternalmed.com compares risk of adverse liver outcomes, cardiovascular events & mortality across steatotic liver disease subtypes ft. @ochoaallemantmd.bsky.social, David Kaplan, @SerperM (@PennGIHep) & @rhubbbstat.bsky.social (@BrownBiostats) jamanetwork.com/journals/jam...
25.06.2025 19:36 β π 1 π 2 π¬ 0 π 0@pennmedicine.bsky.social
@upenn.edu
@pennldi.bsky.social
π¨ Our last paper is out in @jamainternalmed.com
We compared the incidence of adverse liver outcomes, cardiovascular events, and mortality between MASLD, MetALD & ALD and found substantial differences!
π @serperm.bsky.social @rhubbbstat.bsky.social & #DavidKaplan for their mentorship and support!
I would like to thank my mentors for their support and guidance!
@rhubbbstat.bsky.social
#DavidKaplan
@serperm.bsky.social
@pennmedicine.bsky.social
π¨Check out our new study in @jhepatology.bsky.social βοΈ
Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD #MetALD and #ALD
www.journal-of-hepatology.eu/article/S016...
This is an interesting letter to the editor that highlights the pitfalls of poorly validated ICD-10 codes and confirms my growing concerns with the increasingly popular but alarmingly weak TriNetX database and platform
@zachsmithgi.bsky.social
#gisky #liversky